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Background. Mast cells have never been extensively investigated
in renal disease, particularly glomerulonephritis. Recent improve-
ments in monoclonal antibody production to mast cell specific
enzymes have made it possible to study mast cells in tissues more
accurately and easily. Mast cells have been found to secrete basic
fibroblast growth factor (bFGF) in human pulmonary fibrosis.
Methods. Mast cells in 67 cases of IgA nephritis were investi-
gated. Toluidine blue (TB) stainings at pH 5.0 and pH 0.5 were
employed histochemically, and anti-human mast cell tryptase and
chymase monoclonal antibodies were used immunohistochemi-
cally. Anti-bFGF antibody was also used immunohistochemically.
Results. Mast cells were scattered in the interstitium including in
fibrotic areas. TB pH 0.5-positive mast cells were more numerous
than TB pH 5.0-positive mast cells. Immunostaining with anti-
tryptase monoclonal antibody detected more mast cells than the
TB stainings. Mast cells in the interstitium of IgA nephritis had
both tryptase and chymase. Immunoelectron microscopy showed
that tryptase was exclusively localized in the specific granules of
mast cells. The average number of tryptase positive mast cell in
the interstitium of IgA nephritis was lower than that of T
lymphocyte but more than that of macrophages. The average
number of mast cells increased with the progression of interstitial
fibrosis and had a significant correlation with 24-hour creatinine
clearance. Using double labeled immunohistochemistry, some
tryptase-positive mast cells had bFGF in their cytoplasm. Electron
microscopy showed that mast cells were associated with fibroblasts
and/or lymphocytes in the interstitium.
Conclusion. Mast cells are one of the constitutive cells in the
interstitium of IgA nephritis patients and affect renal function by
contributing to the interstitial fibrosis.
Mast cells are bone marrow derived [1, 2 ]. The cells have
high affinity IgE receptors and are known to cause type I
hypersensitivity when cross linked to the receptors [3]. The
granules in mast cells contain various primary inflammatory
mediators, such as histamine, various enzymes, and chemo-
tactic factors. Moreover, mast cells secrete secondary me-
diators, prostaglandin, leukotrienes, and platelet activating
factor. Mast cells have been extensively studied with re-
spect to lung and skin diseases. Recent studies, however,
have revealed that mast cells are actively involved in several
diseases including rheumatoid arthritis [4], diabetes melli-
tus [5], and AIDS [6]. In particular, mast cells have been
shown to play a role in fibrotic processes like scleroderma
[7], pulmonary fibrosis [8], and keloid [9]. Interaction
between fibroblasts and mast cells is essential for fibrosis.
Fibroblasts secrete mast cell growth factors, one of which is
known as c-kit ligand [10]. Recently, mast cells were
identified as the cells that secrete basic fibroblast growth
factor (bFGF) in pulmonary fibrosis [11].
The importance of tubulointerstitial lesions in renal
disease [12, 13], including IgA nephritis, has been stressed
[14]. Macrophages and T lymphocytes have been shown to
be involved in the pathogenesis of tubulointerstitial lesions
[15, 16] possibly through the secretion of growth factors
and cytokines [13]. Although mast cells are known to play
a role in drug-induced tubulointerstitial nephritis [17], they
have never been studied extensively with respect to glomer-
ulonephritis. In the present study we investigated mast cells
in IgA nephritis making use of an immunostaining method
with anti-human mast cell monoclonal antibody and histo-
chemical Toluidine blue (TB) stainings at pH 5.0 and 0.5.
We also tried to check whether the mast cells in the renal
interstitium had bFGF or not. The results showed that mast
cells were one of the constitutive cell types in the intersti-
tium of IgA nephritis patients and contributed to the
interstitial fibrosis resulting in the deterioration of renal
function. In addition, mast cells were found to have bFGF.
METHODS
Sixty-seven cases of primary IgA nephritis in the file of
our department were studied. Patient ages ranged from 4 to
62 years, and the mean age was 28.6 years. The male to
female ratio was 1.2:1. Needle biopsy was performed in 63
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cases and open biopsy in 4 cases. Some patients had
bronchial asthma, but none were known to be allergic to
the drug. Serum IgA values were calculated in 55 cases.
Serum creatinine and blood urea nitrogen (BUN) were
calculated in 58 cases. Urinary protein excretion was cal-
culated in 35 cases. Twenty-four hour creatinine clearance
was calculated in 27 cases. Biopsy samples were fixed
immediately in 30% formaldehyde and embedded in par-
affin. Other samples were snap frozen for immunofluores-
cence or fixed in 2.5% glutaraldehyde for electron micro-
scopical observation. All cases showed the predominant
deposition of IgA in the mesangial area. Control sections
were obtained from 6 patients (39 to 72 years old, mean age
57 years) with nephrectomy due to renal cell carcinoma,
and essentially normal areas without carcinoma invasion
were selected for the study. Paraffin embedded tissues were
cut to 3 microns and stained with TB pH 5.0 for 30 minutes
or TB pH 0.5 (0.5% TB in 0.5 N HCl) for five days [18]. TB
pH 0.5 was counterstained with nuclear fast red.
The clinical data were compared with the average num-
ber of cells in glomeruli or in the interstitium. The degree
of mesangial proliferation was divided into three groups
(minor, mild, moderate) and compared with the mast cell
number. Those with interstitial fibrosis was also divided
into three groups (mild, moderate, severe) and compared.
Biopsy and control specimens were observed with a light
microscope at 3200 magnification using an attached eye
graticle. Cells were counted by the authors without the
knowledge about clinical data. Values were expressed as
the average number of cells per square millimeter of
interstitium or average number of cells per glomeruli.
Immunohistochemistry
The antibodies used for immunohistochemistry are listed
in Table 1. The avidin-biotin complex method (DAKO) or
indirect peroxidase method for double labeled immunohis-
tochemistry was employed. Briefly, sections were deparaf-
finized and washed in Tris buffered saline (TBS). Pretreat-
ment, 1% trypsin (DIFCO, Detroit, MI, USA) digestion for
30 minutes, was done before the incubation with all of the
antibodies except UCHL-1. Peroxidase activity was blocked
by incubation in 1% hydrogen peroxide in methanol for 20
minutes. Then sections were incubated in primary antibod-
ies at 37°C for one hour. After a wash with TBS, biotinyl-
ated anti-mouse and rabbit immunoglobulins were applied
for 15 minutes. Then streptavidin solution was applied
according to the instructions of vendor. Antibody binding
sites were visualized with diaminobenzidine (DAB) and
hydrogen peroxide. As a control for immunohistochemis-
try, sections were incubated in normal mouse or rabbit
serum without the primary antibody. Sections were coun-
terstained with hematoxylin unless otherwise stated.
Serial frozen sections were incubated with anti-tryptase
and chymase antibody. After washing, fluorescent labeled
goat anti-mouse antibody was applied.
For double labeled immunohistochemistry, sections were
first digested with hyaluronidase (Wako Pure Chemical
Industries, Osaka, Japan) and incubated first in a rabbit
antibody to basic fibroblast growth factor (Biomedical
Technologies). After incubation and wash, swine antibody
to rabbit (DAKO) was applied at room temperature for 30
minutes. Visualized with DAB and washed, the sections
were digested with 1% trypsin for 30 minutes, then incu-
bated with an antibody to mast cell tryptase or macrophage
(MAC387) followed by fluorescein-conjugated goat anti-
body to mouse (Organon Technica). Observation was done
with Olympus BX-50 microscope. Tryptase positive cells or
MAC387 positive macrophages were checked for the exis-
tence of bFGF in their cytoplasm.
Electron microscopy
For the electron microscopic observation, glutaraldehyde
fixed specimens were rinsed in phosphate buffer and post-
fixed in 1.5% osmium tetroxide for one hour. After dehy-
dration, these specimen were embedded in Quetol 812.
Ultrathin sections were cut with a diamond knife by LKB
ultramicrotome and stained with uranyl acetate and lead
citrate. Observation was with a JEM 1200 electron micro-
scope. Control cases were not observed electron micro-
scopically.
Immunogold labeling for electron microscopy
Ultrathin sections of glutaraldehyde and osmium fixed
biopsy specimens were cut as described above and mounted
on nickel mesh. These sections were etched by 0.5%
hydrogen peroxide for five minutes. After a wash with
phosphate buffered saline (PBS), the sections were incu-
bated in anti-tryptase antibody diluted to 1:50 in PBS
overnight. After a wash with PBS, 10 nm immunogold
labeled goat anti-mouse IgG (British Bio Cell Interna-
tional, Cardiff, UK) was diluted to 1: 50 with PBS and
applied for 30 minutes. The specimens were then washed
with distilled water and stained with uranyl acetate. Control
sections were processed without primary antibody.
Table 1. Antibodies used in this study
Antibody Animal Specificity
Anti-tryptase (AA-1) mouse mast cell
Anti-chymase mouse mast cell
UCHL-1 mouse T lymphocyte
MAC 387 mouse activated macrophage
CD68 (KP-1) mouse tissue macrophage
Anti-human IgE rabbit
Anti-b-FGF rabbit
Antibodies were from DAKO except b-FGF (basic fibroblast growth
factor) and anti-chymase, which were from CHEMIKON and Biomedical
Technologies, respectively.
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Statistics
Student’s t-test or Aspin-Welch method were used for
the analysis of the relationship between interstitial fibrosis
and mesangial proliferation. Pearsons’ correlation was used
for the analysis of clinical data and the average number of
cells. P , 0.05 was regarded as significant.
Fig. 1. Toluidine blue pH 5.0 (a) and pH 0.5 (b) staining of a control case. A mast cell with round nuclei and metachromatically (a) or
orthochromatically (b) stained granules is found in the interstitium between tubules. Toluidine blue pH 0.5 was counterstained with nuclear fast red
(3900).
Fig. 2. Immunostaining with anti-tryptase monoclonal antibody of a 25-year-old female with IgA nephritis. A mast cell that is polygonal in shape with
cytoplasmic processes can be seen (counterstained with methylgreen; 3900).
Fig. 3. Anti-tryptase monoclonal staining of a 23-year-old female with IgA nephritis. Mast cells (arrows) have infiltrated the tubules (3350).
Fig. 4. Double immunostaining of a 51-year-old male patient with anti-tryptase antibody (a), and anti-basic fibroblast growth factor (bFGF) (b).
Tryptase positive mast cells are scattered in fibrous interstitium and positive for bFGF in this field except one (arrow) (3250).
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RESULTS
Histochemistry
In control sections, mast cells positively stained with TB
were mononuclear with oval shaped cytoplasms. Granules
of mast cells were metachromatically stained purple or
purple red with TB pH 5.0 (Fig. 1a) and orthochromatically
stained blue with TB pH 0.5 (Fig. 1b). TB-positive mast
cells were scattered in the interstitium between tubules,
around glomeruli or blood vessels. TB-positive mast cells
were relatively abundant around large blood vessels or
juxtacortical interstitium, however, no TB-positive mast
cells were found in glomeruli. On average, significantly
more mast cells were stained with TB pH 0.5 (1.2 6
0.4/mm2, mean 6 SE) than TB pH 5.0 (0.7 6 0.2/mm2)
(Table 2). Serial sections showed that a part of mast cells
were positive for both TB stainings. In the IgA nephritis
cases, the distribution pattern for mast cells was almost the
same as in control except a few cells were found in the
tubular lumen. On average, more mast cells were stained
with TB pH 0.5 (10.2 6 1.4/mm2) than TB pH 5.0 (2.4 6
0.5/mm2). The average number of mast cell stained with TB
in IgA nephritis was significantly more than that of control
(Table 2). Similarly, in the controls, some mast cells stained
positively for both TB pH levels (data not shown).
Immunohistochemistry
Cytoplasmic granules of mast cells stained positively with
anti-tryptase monoclonal antibody. The distribution of
mast cell positive for tryptase was the same as for TB
stainings except that only one tryptase positive cell was
found in a glomerulus in the controls (not shown). Tryptase
positive cells were easier to identify than TB positive cells.
Serial control sections showed that TB positive cells were
positive for tryptase. TB negative and tryptase positive cells
were sometimes found. In control, the average number of
tryptase positive mast cells was 1.9 6 0.3/mm2, significantly
more than that of TB pH 0.5 and TB pH 5.0 positive mast
cells (1.2 6 0.4/mm2 and 0.7 6 0.2/mm2, respectively; Table
2). Cytoplasmic processes were not visible in control spec-
imens. In the IgA nephritis cases, some tryptase positive
mast cells were a polygonal shape (Fig. 2). Cytoplasmic
processes were sometimes visible. Only in one case of IgA
nephritis were no tryptase positive cells present in the
interstitium. On average, tryptase-positive mast cells
(23.0 6 2.9/mm2) were significantly more numerous than
histochemically-stained mast cells in the IgA nephritis cases
(TB pH 0.5 and TB pH 5.0, 10.2 6 1.4 and 2.4 6 0.5/mm2,
respectively; Table 2), although 9 out of 67 cases had more
TB pH 0.5 positive than tryptase positive mast cells. The
staining intensity for cytoplasmic granules varied from cell
to cell and granule to granule. Although tryptase positive
mast cells were haphazardly scattered in the interstitium as
seen in the controls, mast cells in the IgA nephritis cases
were frequently seen in fibrotic areas, or around atrophic
tubules or dilatatic tubules with casts. Mast cells rarely
infiltrated the tubules (Fig. 3). Basic fibroblast growth
factor-positive cells were located separately each other in
the interstitium of IgA nephritis cases. Double labeled
immunohistochemistry with anti-bFGF antibody and anti-
mast cell tryptase showed that a part of mast cells had
bFGF in the cytoplasm (Fig. 4). The average number of
bFGF positive cells (4.5 6 1.0 mm2) was significantly lower
than that of tryptase positive cells (23.0 6 2.9). Each case
with IgA nephritis had different percentage of bFGF-
positive mast cells that ranged from 0 to 65%. MAC387
positive macrophages were negative for bFGF. Basic fibro-
blast growth factor-positive cells were found in a few
glomeruli of 3 cases with IgA nephritis. Macrophages and
lymphocytes, but no tryptase positive mast cells, were found
in the glomeruli of IgA nephritis patients. Few tryptase
positive cells were found in the lumen of blood vessels in
the interstitium. The average number of tryptase-positive
mast cells (23.0 6 2.9/mm2 ) was lower than the average
number of T lymphocytes (36.8 6 6.5/mm2) and the
difference was significant. Tryptase-positive mast cells were
more numerous than CD68 positive (15.8 6 3.5/mm2) and
MAC387 positive (21.2 6 3.4/mm2) cells, though the dif-
ference was not significant. The area where inflammatory
cells were accumulated was composed of T lymphocytes
and contained few mast cells (Fig. 5). In control sections,
some tryptase positive mast cells stained positive with
CD68 antibody (not shown). In the control cases it was
possible to distinguish CD68-positive mononuclear mast
cells from CD68 positive macrophages by the latter’s
polygonal shape. However, this was difficult in the IgA
cases because the mast cells were also polygonal. IgE was
positive along the cytoplasmic membrane of the cells in the
interstitium of 20 cases with IgA nephritis. IgE positive
cells were found to be located separately from each other.
Almost all of the IgE positive cells proved to be mast cells
by serial sections. Three out of 20 cases were found to have
diffusely scattered IgE positive cells, some of which were
not able to identify the cell type. These cases were 14-, 24-
and 25-year-old females having severe (2 cases) and mod-
erate (1 case) interstitial fibrosis. Two of them had high
serum IgE values (1935 and 2022 mg/dl) and one of them
had a clinical history of a worsening renal function when a
bronchial asthma attack occurred.
Clinical parameters and mast cell
The average values of serum IgA, BUN and creatinine of
IgA nephritis patients were 357 6 16, 17.3 6 1.1 and 1.1 6
Table 2. Average number of mast cells in the interstitium
Control IgA nephritis
Toluidine blue pH 5 0.7 6 0.2 2.4 6 0.5
Toluidine blue pH 0.5 1.2 6 0.4 10.2 6 1.4
Tryptase positive 1.9 6 0.3a 23.0 6 2.9a
Data are the mean/mm2 6 standard error.
a P , 0.05 vs. Toluidine blue stainings
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0.1 mg/dl, respectively. There was no or little correlation
between the average number of each type of cell per
glomeruli and clinical parameters (data not shown). Several
clinical parameters correlated significantly with the number
of cells in the interstitium (Table 3). All types of cells in the
interstitium including tryptase positive cells correlated sig-
nificantly with BUN and serum creatinine values. Urinary
protein excretion was not correlated significantly with all
types cells except tryptase positive cells. The average
number of interstitial cells correlated significantly with
24-hour creatinine clearances, and the tryptase positive
mast cells had an especially high correlation coefficient (r 5
0.650; Fig. 6). Serum IgA values did not correlate with cell
numbers for any cell type in the interstitium.
Relationship between mesangial cell proliferation,
fibrosis and mast cells
The degree of mesangial proliferation did not correlate
with the number of mast cells. The average number of mast
cells increased significantly with the progression of intersti-
tial fibrosis (Table 4). The average number of the other
interstitial cells also increased with the progression of
interstitial fibrosis (Table 4). The average number of bFGF
expressed cells in severe fibrotic group (10.3 6 3.6) was
significantly more than that in the mild and moderate
fibrotic groups (3.2 6 1.5, 4.0 6 1.2, respectively; Table 4).
Electron microscopy
In IgA nephritis, the number and density of specific
granules in mast cells were variable. Some mast cells were
Fig. 5. The same area from a 25-year-old
female with IgA nephritis is stained with
UCHL-1 (a), and anti-tryptase monoclonal
antibody (b). (a) UCHL-1 is positive where
lymphocytes accumulated (arrow). (b) Tryptase
positive cells are scattered in the interstitium.
No positive cells are found in glomeruli (small
arrows). In this field, the average number of
UCHL-1 and tryptase positive cells in the
interstitium is 344 and 42/mm2, respectively
(3150).
Table 3. Correlation between the clinical parameters and average
number of cells in interstitium
SIgA BUN SCr CCr Uprotein
MAC 0.038 0.625a 0.623a 0.618a 0.275
CD68 0.046 0.657a 0.702a 0.599a 0.280
UCHL-1 0.003 0.492a 0.590a 0.618a 0.344
Tryptase 0.010 0.407a 0.430a 0.650a 0.437a
Abbreviations are: SIgA, serum IgA (mg/dl); BUN (mg/dl), blood urea
nitrogen; SCr, serum creatinine (mg/dl); CCr, 24-hour creatinine clearance
(ml/min); Uprotein, urinary protein excretion per day (g/day).
a P , 0.05
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closely associated with fibroblast like cells and lymphocytes
in the interstitium (Fig. 7). Other mast cells showed no
association with other cell types. Using immunogold meth-
ods, specific granules of mast cells were specifically labeled
with gold particles (Fig. 8). No other cells or cell organelles
were labeled with the particles.
DISCUSSION
Using toluidine blue staining, we showed that in IgA
nephritis and control TB pH 0.5-positive mast cells were
significantly more numerous than TB pH 5.0-positive mast
cells. The effect of formaldehyde should be considered
when evaluating this result since formaldehyde fixation is
known to reduce the number of mast cells stained with TB
[18]. In rats, TB staining is useful for distinguishing sub-
populations of mast cells. Connective tissue mast cells
(CTMC) stain with TB pH 5.0 and mucosal mast cells
(MMC) stain with TB pH 0.5 [19]. In humans, no clear
distinction has been established with respect to TB stain-
ings. In our study, a considerable number of mast cells were
positive for both TB pH 5.0 and TB pH 0.5 stainings as
shown in the serial sections. Therefore, these histochemical
techniques are not useful tools to identify subpopulations
of human mast cells. In humans, Irani et al distinguished
two types of mast cells in Carnoy’s fixed tissues based on
the existence of two enzymes, tryptase and chymase, and
designated them T and TC mast cells, respectively [20]. T
mast cells have tryptase only and exist in the intestinal
mucosa and alveoli of human lung. TC mast cells have both
tryptase and chymase and exist mainly in the submucosa of
the alimentary tract and skin. T and TC mast cells were
thought to be analogous to the MMC and CTMC of rats,
respectively. Unfortunately, we could not use the antibody
to chymase to formalin fixed sections.
Serial frozen sections were checked for the existence of
two enzymes in a mast cell. The results showed that almost
all mast cells in the renal interstitium had both enzymes.
This suggests that the mast cells in the kidney could be TC
type. Curiously, however, chymase positive and tryptase
negative mast cells existed in transplanted kidney (unpub-
lished data).
In the past, only histochemical staining and electron
microscopy were available to identify mast cells. Monoclo-
nal antibodies, however, enable the detection of mast cells
more accurately. Using the mast cell specific enzyme,
tryptase, several monoclonal antibodies that recognize hu-
man mast cells have been developed [21, 22]. The mono-
clonal antibody we used, AA-1, was developed by Walls et
al and stains mast cells specifically in formaldehyde fixed
sections [21]. Our study showed that immunostaining with
this antibody was a more sensitive technique for identifying
mast cells than histochemical methods, even in formalde-
hyde fixed kidney specimens. Walls et al found no signifi-
cant difference in sensitivity between formaldehyde fixation
and Carnoy’s fixation. Our immunoelectron microscopic
analysis using immunogold methods to routinely process
sections also revealed that anti-tryptase antibody specifi-
cally recognized specific granules of mast cells. This sug-
gests that immunostaining with anti-tryptase monoclonal
antibody detects almost all of the mast cells in the renal
interstitium. One tryptase positive cell was detected in a
glomerulus of a control case and a few tryptase positive
cells were found in the capillary lumen of IgA nephritis
cases. It is currently unknown what type of cell these were,
though it may be a basophil since it contained only a small
amount of tryptase (0.04 pg/cell [23] compared with 35 pg
in dermal mast cells [24]). Another possibility is that this
cell is a mast cell precursor, as is found in the rat [2]. Our
study revealed that CD68 antibody recognized some mast
cells in the interstitium of kidney, as in a previous report
[25].
Inflammatory cells have been studied extensively in
Fig. 6. Correlation between the number of cells and the 24-hour creati-
nine clearance. y 5 2 0.870x 1 98.383; r 5 0.650; P , 0.05.
Table 4. Relationship between the average number of cells in
interstitium and the degree of interstitial fibrosis
Tryptase bFGF UCHL-1 MAC 387 CD68
Mild 11.1 6 2.5 3.2 6 1.5 17.7 6 2.8 11.2 6 5.9 7.2 6 1.0
(N 5 32)
Moderate 26.8 6 4.5 4.0 6 1.2 33.2 6 7.1 18.0 6 4.8 10.8 6 3.4
(N 5 25)
Severe 45.5 6 7.7 10.3 6 3.6 102.3 6 30.0 61.0 6 10.9 55.6 6 14.0
(N 5 10)
Data are mean 6 SE. Definitions are: Mild, mild fibrosis of interstitium;
Moderate, moderate fibrosis of interstitium; Severe, severe fibrosis of
interstitium.
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various types of glomerulonephritis, including IgA nephri-
tis [14–16]. Macrophages and T lymphocytes are the pre-
dominant inflammatory cells in the renal interstitium.
Generally, interstitial inflammatory cells are considered to
be more important to renal function than cells in the
glomeruli. There have been few studies about mast cells in
kidney to our knowledge [26, 27]. Our results first demon-
strate that mast cells are one of the constitutive cell types in
the interstitium of IgA nephritis. Renal functional param-
eters (BUN, urinary protein excretion, 24-hr creatinine
clearance) are significantly correlated with the number of
mast cells. Basic fibroblast growth factor is expressed in
Fig. 7. Electron micrograph of a 44-year-old
male with IgA nephritis. A fibroblast (F),
lymphocyte (L), and mast cell (M) are
associated and attached by processes (arrows)
(36000).
Fig. 8. Specific granules in a mast cell are
selectively labeled with 10 nm gold particles
(334,000).
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the cytoplasm of mast cells in the interstitium. Electron
microscopical observation reveals that mast cells are often
closely associated with fibroblast-like cells cooperating with
lymphocytes and macrophages in the fibrous interstitium of
IgA nephritis patients. Fibroblast and mast cells are known
to influence each other [10, 11]. Mast cell granule synthesis
has been reported to be dependent on fibroblasts [28].
Taken together, these data indicate that mast cells are
actively involved in the fibrotic process with lymphocytes,
macrophages, and fibroblasts in the interstitium in IgA
nephritis.
Platelet-derived growth factor and transforming growth
factor-beta have been shown to be expressed in kidney of
patients with IgA nephritis [29]. Human dermal mast cell
are already known to produce and secrete tumor necrosis
factor alpha [30]. Interleukin (IL)-4, IL-5 and IL-6 are
identified in the cytoplasm of mast cells in the nasal mucosa
[31]. Recently, Qu et al found mast cells as a major source
of bFGF in pulmonary fibrosis and skin hemangioma [11].
Also in our study, tryptase-positive mast cells were found to
selectively express bFGF. Basic FGF correlated with the
degree of interstitial fibrosis of IgA nephritis. In lung,
bFGF is produced more in the early stage of disease [32].
This suggests that mast cells play different roles in the
kidney; however, further study of growth factor expression
and fibrosis is needed. As the bFGF was expressed in
glomeruli, this growth factor might be produced from
other, as yet unidentified cells.
The mechanism by which mast cells proliferate in the
interstitium in IgA nephritis is not known. Mast cell
proliferation has been observed in skin with scleroderma,
where the mechanism of mast cell appearance is considered
to involve IL-3 and/or IL-4 stimulation by helper T lym-
phocytes [33]. If the mast cells in the interstitium of the
kidney is identical with the TC type mast cell in the gut,
then T lymphocyte-dependent proliferation is unlikely be-
cause only the T type mast cells have been shown to be
dependent on the T lymphocyte [6]. The average number of
mast cells increased with the progression of interstitial
fibrosis. It is not possible to decide from this study whether
or not mast cell increased as a result of fibrosis.
IgE bearing cells were identified in some cases with IgA
nephritis. Two cases had diffuse IgE positive infiltration in
the interstitium with progressed fibrosis and a high serum
IgE value. One case, moreover, had asthma that caused
poor renal function after an asthmatic attack. These data
suggest that type I hypersensitivity is involved in the
formation of interstitial lesion in some cases of IgA nephri-
tis. Drug-induced tubulointerstitial nephritis is sometimes
caused by type I allergy [17]. However, in our cases with
IgE positive cells, any changes such as plasma cell and
eosinophil infiltration that could indicate a drug-induced
interstitial nephritis were not observed. None of the pa-
tients in the present study had an allergy to the drug.
This paper is the first to our knowledge to describe the
importance of mast cells in the interstitium in IgA nephri-
tis. Mast cells should be investigated further in renal
disease.
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